Prevalence of urinary symptoms in women with parametrial endometriosis - Systematic review and meta-analysis
Abstract
OBJECTIVE
This study aimed to evaluate the prevalence of urinary symptoms in women with parametrial endometriosis before and after surgery.
DATA SOURCES
We systematically searched MEDLINE, Web of Science, and Scopus through March 2025, with no language or publication year restrictions. Reference lists of included studies and relevant reviews were also screened.
METHODS OF STUDY SELECTION
Studies reporting pre- and/or postoperative urinary symptoms in women with parametrial endometriosis were included. A systematic review and meta-analysis, including 21 articles, was conducted.
TABULATION, INTEGRATION, AND RESULTS
Data were extracted and categorized into dysuria, lower urinary tract symptoms (LUTS), and voiding dysfunction. Preoperatively, dysuria affected 15% (95% CI: 5-35) of women, with a mean VAS score of 1.10 (95% CI: 0.90-1.30). LUTS affected 27% (95% CI: 10-56), with a mean BFLUTS score of 13.23 (95% CI: -1.26-27.72). Voiding dysfunction was scarcely reported before surgery. Postoperatively, the prevalence of LUTS decreased to 13% (95% CI: 7-25), and the mean BFLUTS score to 7.84 (95% CI: -0.36-16.03). Voiding dysfunction was experienced in 14% of women (95% CI: 5-32), and 12% were symptoms that persisted after discharge (95% CI: 6-23). Subgroup analysis suggested a trend toward lower postoperative voiding dysfunction prevalence in patients with uterosacral involvement compared with those with lateral parametrium involvement.
CONCLUSION
Urinary symptoms are common in…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling
- Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues
- Luteolin Inhibits Dexamethasone‐Induced Osteoporosis by Autophagy Activation Through miR‐125b‐5p/SIRT3/AMPK/mTOR Axis, an In Vitro and In Vivo Study
- Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes
- Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI‐RS 2023
- Chylomicron-mimicking supramolecular nano emulsion for oral luteolin delivery against hyperuricemia
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.